Percutaneous Fetal Cardiac Interventions for Structural Heart Disease

Computed Tomography for Structural Heart Disease and Interventions.

Transcatheter cardiac interventions are a fast evolving field. The past decade has seen the development of transcatheter aortic valve replacement, transcatheter mitral valve repair and replacement, septal defect closure devices and left atrial appendage closure devices for thromboprophylaxis. More than ever, medical imaging is taking a central role in the care of patients with structural heart ...

Percutaneous interventions in stenotic valvular heart disease complicating pregnancy.

Heart disease complicating pregnancy is a common and serious clinical condition. Cardiac disease does not preclude pregnancy but increases the risk to both the mother and the foetus, despite state-of-the-art obstetric and cardiac care. The incidence of maternal heart disease in Sri Lanka is about 1.5 per hundred deliveries. About 70% are of rheumatic origin [1]. It causes chronic valvular lesio...

Percutaneous interventions in aortic disease.

Fetal cardiac interventions: clinical and experimental research

Fetal cardiac interventions for congenital heart diseases may alleviate heart dysfunction, prevent them evolving into hypoplastic left heart syndrome, achieve biventricular outcome and improve fetal survival. Candidates for clinical fetal cardiac interventions are now restricted to cases of critical aortic valve stenosis with evolving hypoplastic left heart syndrome, pulmonary atresia with an i...

Training in structural heart interventions.

O ver the last decade, there have been tremendous advances in our ability to treat valvular heart disease and anatomic cardiac defects utilizing catheter-based approaches. At the same time, the number of patients with acquired valvular heart disease or adult congenital heart disease who may benefit from these procedures has grown at a rapid pace—and will continue to grow with the aging populati...